ATLAS / Macro Radar / Reporting / TCRX

TScan Therapeutics, Inc. (TCRX) reporting calendar

TScan Therapeutics, Inc. files periodic reports with the SEC as TCRX on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
29 Jul 2026 – 26 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001193125-26-207572
10-K31 Dec 20254 Mar 202663 days0001193125-26-089884
10-Q30 Sep 202512 Nov 202543 days0001193125-25-275933
10-Q30 Jun 202512 Aug 202543 days0000950170-25-106919
10-Q31 Mar 20256 May 202536 days0000950170-25-063968
10-K31 Dec 20245 Mar 202564 days0000950170-25-033077
10-Q30 Sep 202412 Nov 202443 days0000950170-24-124575
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095066
10-Q31 Mar 202413 May 202443 days0000950170-24-058198
10-K31 Dec 20236 Mar 202466 days0000950170-24-026875
10-Q30 Sep 20239 Nov 202340 days0000950170-23-061533
10-Q30 Jun 202310 Aug 202341 days0000950170-23-040961
10-Q31 Mar 202310 May 202340 days0000950170-23-020087
10-K31 Dec 20228 Mar 202367 days0000950170-23-006589
10-Q30 Sep 20229 Nov 202240 days0000950170-22-023507
10-Q30 Jun 202210 Aug 202241 days0000950170-22-016263
10-Q31 Mar 202212 May 202242 days0000950170-22-009472
10-K31 Dec 20219 Mar 202268 days0000950170-22-003175
10-Q30 Sep 202110 Nov 202141 days0000950170-21-003918
10-Q30 Jun 202119 Aug 202150 days0001564590-21-045079

Source: SEC EDGAR company submissions for CIK 0001783328. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.